Patents by Inventor Jacob Orme

Jacob Orme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System for selective cell treatment using ideotypically modulated pharmacoeffectors
    Patent number: 8518409
    Abstract: In a method embodiment, a method includes introducing a plurality of Ideotypically Modulated Pharmacoeffectors (IMP) into a population of cells. Each IMP may include a detection domain and an activation domain. One or more epitopes is bound by the detection domain. The activation domain is activated in response to the binding. Applications may include but are not limited to viral infections, other intracellular infections, cancers, vector-borne diseases, autoimmune diseases, cellular diseases, cellular enhancement, and research.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: August 27, 2013
    Assignee: Imperium Biotechnologies, Inc.
    Inventor: Jacob Orme
  • Methods of using ideotypically modulated pharmacoeffectors for selective cell treatment
    Patent number: 8383405
    Abstract: In a method embodiment, a method includes introducing a plurality of Ideotypically Modulated Pharmacoeffectors (IMP) into a population of cells. Each IMP may include a detection domain and an activation domain. One or more epitopes is bound by the detection domain. The activation domain is activated in response to the binding. Applications may include but are not limited to viral infections, other intracellular infections, cancers, vector-borne diseases, autoimmune diseases, cellular diseases, cellular enhancement, and research.
    Type: Grant
    Filed: May 31, 2010
    Date of Patent: February 26, 2013
    Assignee: Imperium Biotechnologies, Inc.
    Inventor: Jacob Orme
  • IDEOTYPICALLY MODULATED PHARMACOEFFECTORS FOR SELECTIVE CELL TREATMENT
    Publication number: 20110293639
    Abstract: In a method embodiment, a method includes introducing a plurality of Ideotypically Modulated Pharmacoeffectors (IMP) into a population of cells. Each IMP may include a detection domain and an activation domain. One or more epitopes is bound by the detection domain. The activation domain is activated in response to the binding. Applications may include but are not limited to viral infections, other intracellular infections, cancers, vector-borne diseases, autoimmune diseases, cellular diseases, cellular enhancement, and research.
    Type: Application
    Filed: May 26, 2011
    Publication date: December 1, 2011
    Inventor: Jacob Orme
  • Ideotypically Modulated Pharmacoeffectors For Selective Cell Treatment
    Publication number: 20110294188
    Abstract: In a method embodiment, a method includes introducing a plurality of Ideotypically Modulated Pharmacoeffectors (IMP) into a population of cells. Each IMP may include a detection domain and an activation domain. One or more epitopes is bound by the detection domain. The activation domain is activated in response to the binding. Applications may include but are not limited to viral infections, other intracellular infections, cancers, vector-borne diseases, autoimmune diseases, cellular diseases, cellular enhancement, and research.
    Type: Application
    Filed: May 31, 2010
    Publication date: December 1, 2011
    Inventor: Jacob Orme